E-LIB Suche - Ergebnisse für: Traboulsee, A.

1

P.014 Intravenous immunoglobulin use for central nervous sy..:

Beadon, K ; Uy, C ; Cross, H...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 51 (2024) s1 - p. S18-S18 , 2024

Link: https://doi.org/10.1017/..

2

P.108 Use of intravenous immunoglobulin for central nervous..:

Uy, C ; Cross, HM ; Percy, J...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 49 (2022) s1 - p. S36-S37 , 2022

Link: https://doi.org/10.1017/..

3

Quantitative MRI findings indicate diffuse white matter dam..:

Johnson, P ; Chan, JK ; Vavasour, IM...
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 8 (2022) 1 - p. 205521732210788 , 2022

Link: https://doi.org/10.1177/..

4

Diffusely abnormal white matter in clinically isolated synd..:

Vavasour, I.M. ; Becquart, P. ; Gill, J....
Multiple Sclerosis and Related Disorders. 57 (2022) - p. 103422 , 2022

Link: https://doi.org/10.1016/..

5

POSB56 Cost-Effectiveness of Satralizumab Compared to Eculi..:

Vicente, C ; Diles, D ; Di Maio, D...
Value in Health. 25 (2022) 1 - p. S71 , 2022

Link: https://doi.org/10.1016/..

6

P.080 Cognitive Profile, Disease Characteristics, and Neuro..:

Chivukula, P ; Chan, J ; Johnson, P...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48 (2021) s3 - p. S42-S42 , 2021

Link: https://doi.org/10.1017/..

7

P.048 International MAGNIMS-CMSC-NAIMS consensus recommenda..:

Traboulsee, A ; Wattjes, M ; Ciccarelli, O...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48 (2021) s3 - p. S32-S33 , 2021

Link: https://doi.org/10.1017/..

8

P.091 Consensus Guidelines for Utilization and Monitoring o..:

Uy, CE ; Cross, HM ; Percy, J...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48 (2021) s3 - p. S45-S45 , 2021

Link: https://doi.org/10.1017/..

9

Efficacy of satralizumab as monotherapy in pre-specified su..:

Bennett, Jeffrey L. ; Greenberg, B. ; Traboulsee, A....
Journal of the Neurological Sciences. 405 (2019) - p. 172 , 2019

Link: https://doi.org/10.1016/..

10

Efficacy and safety of satralizumab monotherapy for relapse..:

Traboulsee, A. ; Greenberg, B. ; Bennett, J.L....
Journal of the Neurological Sciences. 405 (2019) - p. 171 , 2019

Link: https://doi.org/10.1016/..

11

FLAIR2 improves LesionTOADS automatic segmentation of multi..:

Le, M. ; Tang, L.Y.W. ; Hernández-Torres, E....
NeuroImage: Clinical. 23 (2019) - p. 101918 , 2019

Link: https://doi.org/10.1016/..

12

Cannabis-based product use in a multiple sclerosis cohort:

Schabas, AJ ; Vukojevic, V ; Taylor, C...
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 5 (2019) 3 - p. 205521731986936 , 2019

Link: https://doi.org/10.1177/..

13

03:09 PM Abstract No. 94 A multicenter prospective randomiz..:

Machan, L. ; Klass, D. ; Siskin, G...
Journal of Vascular and Interventional Radiology. 30 (2019) 3 - p. S44-S45 , 2019

Link: https://doi.org/10.1016/..

14

P.027 Efficacy of a fourth alemtuzumab course in RRMS patie..:

Traboulsee, A ; Alroughani, R ; Boster, A...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 45 (2018) s2 - p. S23-S23 , 2018

Link: https://doi.org/10.1017/..

15

Long-term Reduction in Brain MRI Disease Activity and Atrop..:

Arnold, D.L. ; Kappos, L. ; Hauser, S.L....
Multiple Sclerosis and Related Disorders. 26 (2018) - p. 265 , 2018

Link: https://doi.org/10.1016/..